Masimo
NASDAQ: MASI ~$8B MCAP
Global medical technology company developing noninvasive patient monitoring technologies, pulse oximetry, and wearable sensors.
Company Info
Upcoming Milestones & Key Dates
2026-Q3
Regulatory
Root LiDCO FDA 510(k) clearance announced
Clinical Development Pipeline
Root with LiDCO
Target: Noninvasive monitoringSafetyNet
Target: Wearable sensorsW1
Target: Continuous monitoringRecent News
No recent news updates available for this company.
Leadership Team
Joe Kiani
Founder and CEO
Micah Young
CFO
Bilal Muhsin
COO